BIOMAT Database Logo BIOMAT Database Logo

Monitoring free plasma concentrations of phenytoin. 1984

G M Peterson, and S McLean

UI MeSH Term Description Entries
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014462 Ultrafiltration The separation of particles from a suspension by passage through a filter with very fine pores. In ultrafiltration the separation is accomplished by convective transport; in DIALYSIS separation relies instead upon differential diffusion. Ultrafiltration occurs naturally and is a laboratory procedure. Artificial ultrafiltration of the blood is referred to as HEMOFILTRATION or HEMODIAFILTRATION (if combined with HEMODIALYSIS).

Related Publications

G M Peterson, and S McLean
Phenytoin-phenobarbital interaction: importance of free plasma phenytoin monitoring.
July 1988, Pharmacological research communications,
G M Peterson, and S McLean
Effect of valproate on free plasma phenytoin concentrations.
July 1984, British journal of clinical pharmacology,
G M Peterson, and S McLean
Clinical decision support of therapeutic drug monitoring of phenytoin: measured versus adjusted phenytoin plasma concentrations.
February 2012, BMC medical informatics and decision making,
G M Peterson, and S McLean
Conjugate lateral gaze nystagmus and free phenytoin concentrations in plasma: lack of correlation.
February 1978, Epilepsia,
G M Peterson, and S McLean
Can phenytoin lower plasma fibrinogen concentrations?
August 1995, Thrombosis research,
G M Peterson, and S McLean
Aberrantly high phenytoin concentrations in saliva. Precaution in monitoring phenytoin concentrations in whole saliva.
November 1979, British journal of clinical pharmacology,
G M Peterson, and S McLean
Serial free and plasma valproic acid and phenytoin monitoring and drug interactions.
January 1981, Therapeutic drug monitoring,
G M Peterson, and S McLean
Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children.
September 2006, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,
G M Peterson, and S McLean
Phenytoin plasma concentrations in paroxysmal kinesigenic choreoathetosis.
June 1980, Neurology,
G M Peterson, and S McLean
Is routine measurement of free phenytoin concentrations rational?
August 1995, Therapeutic drug monitoring,
Copied contents to your clipboard!